Raymond James Financial
PASG icon

Raymond James Financial’s Passage Bio PASG Stock Holding History

Raymond James Financial’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-320
Closed -$2.56K – 6217
2025
Q2 		$2.56K Buy
+320
New +$2.34K ﹤0.01% 6349

Other funds holding PASG

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James Financial's PASG Position: Q3 2025 in Review

Raymond James Financial sold out of Passage Bio (PASG) in Q3 2025, closing a stake of 320 shares — an estimated $2.56K sold.

Raymond James Financial first reported a position in PASG in Q2 2025 and held it in 1 quarter. The position peaked at $2.56K in Q2 2025. 32 funds tracked by Wall St. Rank hold PASG as of Q3 2025.

  • Raymond James Financial reported no remaining Passage Bio position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 320 Passage Bio shares in Q3 2025, an estimated $2.56K.
  • Raymond James Financial first reported a position in Passage Bio in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's Passage Bio position peaked at $2.56K in Q2 2025.
  • 32 funds tracked by Wall St. Rank held Passage Bio as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.